Angel Investor / Advisor

• Jan 2023 - Present

LATAM Managing Director (DASA GENÔMICA)

• Jan 2020 - Present

# Manage DASA GENOMICA with more than 400 employers. It is the biggest genetic company in LATAM composed by GeneOne, Genia, Insitus, Cytogene, Chromosome and Genera (DTC) acting in many different genetic areas such as oncogenetics, cardiogenetics, neurogenetics, rare disease, oncohemato, farmacogenetic, human reproduction, oftalmology, ancestrally and wellness. # Lead a specialized team composed by geneticists, bioinformats, marketing, sales, operations, production, commercial team, etc.…# Structure the strategy and partnerships with HMOs, hospitals, clinics, physicians and pharmaceutical companies to foster and maximize genetic testes across Brazil and LATAM.# Boost Genera our DTC company GO TO Market strategy to gain market share in the wellness arena (ancestrally, nutrition, paternity, etc...).# Lead and structure DASA clinical research area, PSP´s (patient support programs), RWE (real world evidence studies) and Central Lab partnering with pharmaceutical companies and CRO´s.

Brazil Managing Director (DASA GENÔMICA)

• Jun 2019 - Dec 2019

# Manage DASA GENOMICA with more than 400 employers. It is the biggest genetic company in Brasil composed by GeneOne, Insitus, Cytogene, Chromosome and Genera (DTC) acting in many different genetic areas such as oncogenetics, cardiogenetics, neurogenetics, rare disease, oncohemato, farmacogenetic, human reproduction, oftalmology, ancestrally and wellness. # Lead a specialized team composed by geneticists, bioinformats, marketing, sales, operations, production, commercial team, etc.…# Structure the strategy and partnerships with HMOs, hospitals, clinics, physicians and pharmaceutical companies to foster and maximize genetic testes across Brazil.# Boost Genera our DTC company GO TO Market strategy to gain market share in the wellness arena (ancestrally, nutrition, paternity, etc...).# Lead and structure DASA clinical research area, PSP´s (patient support programs), RWE (real world evidence studies) and Central Lab partnering with pharmaceutical companies and CRO´s.

Commercial (institutional and retail) & Business Unit Director

• Apr 2017 - May 2019

# Managed more than 120 people (mkt, sales, trade mkt, training, KAM, tenders, digital) in two different Business Units and three areas: commercial, marketing/sales and tenders. ▪ Restructured AstraZeneca’s indirect sales regarding all Business Units (Onco, Diabetes, Respiratory and Cardio & Gastro), with over USD 0.5 billion in sales (20% growth YoY) and in charge for all strategical interactions, KPIs (OTIF, Fill rate, SIT, etc.…) and projects with pharmacy chains and wholesalers. # Managed the tender department with direct and indirect participation representing 10% of total AstraZeneca sales. # Worked in synergy with the Market Access team, discussing and approving all strategies regarding institutional and private accounts. # Led the Cardio & Gastro Business Unit (total sales of 0.25 billion with the 3rd most sold retail product in 2018 - Selozok) composed by a team of 90 hybrid sales reps covering more than 16,000 physicians and 10,000 pharmacies with a continuous double-digit growth in annual sales even in a very competitive market with many generics. # Structured the strategy and partnerships with other BUs for all established Onco (Arimidex, Casodex and Nolvadex), Respiratory with Losec Mups, Hospital Products (Nexium IV and Seloken) as well as the external partnership with Medley regarding generic Selozok and Nexium. # Implemented innovative digital strategies to reach non-covered physicians in cost prohibitive areas and maximized customer experiences in the patient support program creating unique experiences.

Commercial & Market Access & Business Unit Head – Medical Devices

• May 2016 - Apr 2017

# Managed the Hospital Business Units responsible for more than 100 people (mkt, sales, sales excellence, market access, tenders, KAM, medical, events and digital) with sales of USD 0.2 billion. Also, restructured the business strategy and marketing plans of all core products of two different divisions: wound care and sterilization. # Reshaped and led a team of 50 direct and 50 indirect sales reps covering more than 2,500 private and public hospitals across Brazil. # Developed, managed and implemented new tools to maximize growth and share in both public and private markets to reach annual sales objectives as well as long term business opportunities. # Re organized all 25 wholesalers that worked with 3M and developed new business models to guarantee the business unit growth. # Created the market access department and implemented risk sharing models with key stakeholders.

Business Unit & Market Access Director – Medical Devices & Specialties

• Apr 2014 - May 2016

# Developed, managed and led the two Business Units, managing more than 30 people in three different areas: marketing/sales, market access and tenders. # Managed both public and private markets to reach annual sales objectives of USD 0.1 billion as well as long term business opportunities. # Structured the Retina Business Unit regarding business strategy for vitrectomy equipment’s such as Accrus and Constellation along with all surgery supporting materials as well as was responsible for the launch of retina specialty products such as Jetrea for Vitreo Macular Traction (VMT) and RTH for Wet AMD. # Managed all institutional and tender’s teams, public wholesalers as well as stakeholder management (Public Institutions and HMO’s). # Created and developed synergy with Novartis KAM´s (private and institutional) to boost the Medical Devices and Specialties business growth through risk sharing models with key stakeholders. # Developed health economics materials and dossier to support private and public submission and approval for Jetrea.

PMO - New Products & Life Cycle Strategy Senior Manager

• Jun 2012 - Apr 2014

# Created a robust New Products & Life Cycle Strategy process and integrated areas to better leverage new products strategy.# Implemented all Novartis new products pre-launch plans (Entresto, Cosentyx, Seebri, Onbrize, Serelaxin, Xolair for Urticaria, etc…), with inputs from local cross-functional team (Medical, Regulatory, Market Access, Market Intelligence, etc.…); aligned with Business Franchise Heads and Global/Region Teams, creating an integrated approach to maximize launches and extend/protect product lifecycle.

Senior Product Manager – Neuroscience Specialty market (Job Rotation as First Line Manager)

• May 2011 - Jun 2012

# Selected for a yearlong job rotation program as a First Line Manager, responsible for 17 Brazilians states.# Managed Gilenya launch, Exelon, Ritalin and Stalevo/Comtan promotion on private and public institutions which involved executing the strategy, managing sales as well as leading and motivating the team (15 CT’s).

MBA Summer Internship – Oncology

• Jun 2010 - Aug 2010

# Developed the launch readiness plan for new oncology products (Caelyx, Yondelis and Abiraterona) to be launched in Brazil in matters such as sales objectives, marketing strategy, advertising campaigns, market potential, competition, etc... # Developed the launch readiness plan for new oncology products (Caelyx, Yondelis and Abiraterona) to be launched in Brazil in matters such as sales objectives, marketing strategy, advertising campaigns, market potential, competition, etc...

Market Intelligence Analyst (All Market Intelligence Department)

• Aug 2004 - Nov 2005

# Managed all the Market Intelligence Department, processing and analyzing all data such as IMS (demand), Close Up (prescription), market researches, etc.…, for all marketing and sales departments.

Marketing Analyst – (Job Rotation as a Sales Rep and led a POS Project) – Diabetes

• Aug 2003 - Aug 2004

# Worked in the field force as a Sales Rep for 7 months to better understand our client (physicians/ pharmacies) and our sales force needs.

Trainee – (Latin America) – Diabetes

• Dec 2002 - Aug 2003

Engaged in a job rotation program that focused on finance, sales, marketing and human resources.